The promoters of PD-1, CTLA-4, and Tim3 were significantly hypomethylated in breast cancer compared to normal tissues, and increased expression of these genes and epi-modifications are likely to lead to tumor immune evasion. This evidence concerns the gene HAVCR2 and breast cancer.